Alger Russell Innovation ETF (INVN)

The Alger Russell Innovation ETF (INVN, on NASDAQ) is an actively managed equity fund that buys U.S. stocks of companies at the forefront of technological innovation and disruption. It combines Fred Alger Management’s long-standing philosophy of growth investing with a focus on companies developing or deploying new technologies — from software and semiconductors to biotechnology and industrial automation.

The Alger innovation philosophy

Alger is one of the longer-standing active growth-investment shops in the United States, with roots going back to the 1960s. The firm has built a reputation on fundamental research into emerging companies and industries, betting on the winners before the broader market recognizes them as winners. The innovation focus in INVN reflects this heritage: the fund is constructed around the belief that companies solving new problems or disrupting established industries, through technology or business-model innovation, can deliver superior long-term returns.

This is not sector investing in the traditional sense — INVN is not simply “the technology ETF.” Rather, the fund looks for innovative companies wherever they emerge. It might own a fintech startup, a biotech researcher working on gene therapy, a materials-science company developing new semiconductors, or an industrial company using artificial intelligence to optimize manufacturing. The common thread is the potential for significant competitive advantage or market creation through innovation.

Portfolio characteristics and holdings

INVN typically holds between 50 and 100 stocks, which is concentrated relative to a broad market fund but not an extreme concentration. The portfolio tends to skew toward smaller and mid-cap companies — the size range where disruption often begins — though the fund also holds some larger companies that are still driving innovation (such as established technology giants making major investments in new domains).

The portfolio is not static. Alger’s research teams continually evaluate companies, and holdings turn over as companies’ innovation potential evolves or as better opportunities emerge elsewhere. This active management means INVN’s composition can drift significantly from the broader market over time, especially in sectors or company sizes that are out of favour.

The fund is positioned toward growth — companies whose earnings are expected to expand faster than the broader market. This makes INVN more volatile than a diversified equity fund, especially in environments where the market rotates away from growth toward value or dividend-paying stocks.

Sector tilts and concentration

INVN is deliberately overweight technology and healthcare — sectors where innovation is concentrated — and likely underweight or absent from energy, utilities, and consumer staples, where innovation is less central to competitive advantage. Within technology, the fund might emphasize software, semiconductors, and internet companies. Within healthcare, it might focus on biotech, medical devices, and healthcare IT.

This tilt is a feature, not a bug. The fund’s managers believe innovation creates superior returns, and they are willing to accept the risk of sector concentration to capture those returns. But concentration is a risk: if technology and healthcare stocks fall out of favour, INVN will feel the decline more sharply than a diversified fund.

Costs and the active-management question

INVN carries an expense ratio typically in the 0.65 to 0.75 percent range, higher than a passive index ETF but lower than many traditional mutual funds pursuing similar strategies. For an investor holding the fund for years, this fee compounds, and it reduces returns by that amount before any active outperformance is considered.

The central question for any active growth fund is whether the manager’s stock-picking skill can add enough value to overcome the fee and beat the passive alternative. For INVN, the relevant benchmark is likely a broad U.S. growth index or a diversified equity index. Over rolling 5- and 10-year periods, has Alger’s fundamental research and innovative-company focus delivered returns above a simple technology or growth index fund? The answer has varied across time periods and market cycles.

Growth-stock volatility and drawdown risk

Because INVN is positioned toward growth and smaller-cap companies, it carries heightened volatility. In bull markets driven by growth optimism — particularly in rising rates of new-company creation and venture funding — INVN can outperform significantly. In bear markets, especially those driven by rising interest rates or profit-taking in overvalued growth names, the fund can underperform and drawdown sharply.

The 2022 bear market illustrated this dynamic: growth and technology stocks, which had dominated returns during 2020–2021, fell significantly when investors rotated toward value and more defensive holdings. INVN would have experienced a larger drawdown than a diversified equity fund. An investor must be comfortable with this volatility to own the fund, particularly in the short to medium term.

Research and the fundamental-value thesis

At the core of INVN’s approach is the belief that Alger’s research team — meeting with company management, analyzing technology trends, and evaluating competitive dynamics — can identify companies with genuine innovation moats or market-creation potential before that potential is widely recognized by the market. This is the classic active-management thesis: the research produces insight that the market hasn’t yet priced in, creating an edge.

The challenge is that this thesis has become more crowded. Hundreds of active managers and hedge funds are also hunting for innovative companies, and venture-capital money has flooded the space, making it harder to find true “undiscovered” gems. Additionally, the rise of index investing and passive strategies has reduced the proportion of capital deployed by active stock-pickers, potentially making their edge smaller even if it exists.

Tracking INVN and understanding the trade-off

An investor in INVN is making a bet that Alger’s fundamental research will generate returns above what a simple passive growth index would deliver. To evaluate this bet, compare INVN’s returns to appropriate benchmarks — such as a U.S. growth index ETF or a broader equity index — over rolling periods of 3, 5, and 10 years. Pay attention to both absolute returns and returns on a risk-adjusted basis (how much volatility the fund had to endure to achieve those returns).

Watch the fund’s cash position (uninvested cash is a drag on returns) and the turnover rate (high turnover indicates frequent trading, which generates transaction costs and tax consequences). Finally, stay aware of sector and size rotations in the broader market: when smaller-cap and technology stocks fall out of favour, INVN is likely to underperform, and the strength of conviction required to hold through those periods is significant.